Page 184 - Liver Diseases in Children

174 โรคตับในเด็ก

pthaigastro.org
เอกสำรอ้ำงอิง

1. Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN clinical practice
guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations
from the expert committee on NAFLD (ECON) and the North American Society of Pediatric
Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319-34.
2. Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic
fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One
2015;10:e0140908.
3. Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med
2017;377:2063-72.
4. Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P. Non-alcoholic fatty liver disease:

an update with special focus on the role of gut microbiota. Metabolism 2017;71:182-97.
5. Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, et al. Sucrose-sweetened
beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention
study. Am J Clin Nutr 2012;95:283-9.
6. Goyal NP, Schwimmer JB. The genetics of pediatric nonalcoholic fatty liver disease. Clin Liver Dis
2018;22:59-71.
7. Della Corte C, Mosca A, Lucidi V, Alterio A, Nobili V. Non-alcoholic steatohepatitis in childhood. In:
th
Kelly DA, editor. Diseases of the liver and biliary system in children. 4 ed. West Sussex: John Wiley &
Sons Ltd; 2017. p. 227-40.

8. Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: recent solutions,
unresolved issues, and future research directions. World J Gastroenterol 2016;22:8078-93.
9. Schwimmer JB. Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology 2016;63:1718-25.
10. Schwimmer JB, Newton KP, Awai HI, Choi LJ, Garcia MA, Ellis LL, et al. Paediatric gastroenterology
evaluation of overweight and obese children referred from primary care for suspected non-alcoholic
fatty liver disease. Aliment Pharmacol Ther 2013;38:1267-77.
11. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children
and adolescents. Pediatrics 2006;118:1388-93.
12. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB. Evidence and recommendations for imaging
liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2014;12:765-73.
13. Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, et al. Magnetic resonance

imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver
disease. Hepatology 2015;61:1887-95.
14. Middleton MS, Van Natta ML, Heba ER, Alazraki A, Trout AT. Diagnostic accuracy of magnetic resonance imaging
hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 2018;67:858-72.